Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics (Cancer Drug Discovery and Development)
ISBN-13:
9781468498479
ISBN-10:
1468498479
Edition:
Softcover reprint of the original 1st ed. 2004
Author:
MaryAnn Foote, George Morstyn, Graham J. Lieschke
Publication date:
2012
Publisher:
Humana
Format:
Paperback
487 pages
FREE US shipping
Book details
ISBN-13:
9781468498479
ISBN-10:
1468498479
Edition:
Softcover reprint of the original 1st ed. 2004
Author:
MaryAnn Foote, George Morstyn, Graham J. Lieschke
Publication date:
2012
Publisher:
Humana
Format:
Paperback
487 pages
Summary
Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics (Cancer Drug Discovery and Development) (ISBN-13: 9781468498479 and ISBN-10: 1468498479), written by authors
MaryAnn Foote, George Morstyn, Graham J. Lieschke, was published by Humana in 2012.
With an overall rating of 3.9 stars, it's a notable title among other
books. You can easily purchase or rent Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics (Cancer Drug Discovery and Development) (Paperback) from BooksRun,
along with many other new and used
books
and textbooks.
And, if you're looking to sell your copy, our current buyback offer is $0.3.
Description
Leading oncologists, hematologists, and nephrologists comprehensively review the role of HGFs in clinical practice, explain the molecular basis of their effects, and consider potential future developments. The authors focus on the use of HGFs in oncology, describing their cutting-edge application to patients with lung cancer, Hodgkin's and nonhodgkin's lymphoma, breast cancer, chronic lymphocytic leukemia, AIDS-related malignancies, myelodysplastic syndromes, and aplastic anemias. Among the HGFs described are granulocyte colony-stimulating factor, erythropoietc factors, thrombopoietic factors, and stem cell factor and its receptor, C-kit. To complete their survey, the contributors also consider the safety and economic implications of HGFs and the future potential for HGF antagonists in oncology.
We would LOVE it if you could help us and other readers by reviewing the book
Book review
Congratulations! We have received your book review.
{user}
{createdAt}
by {truncated_author}